You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page.
Turn on more accessible mode
Turn off more accessible mode
Skip Ribbon Commands
Skip to main content
Turn off Animations
Turn on Animations
SharePoint
Sign In
Use SHIFT+ENTER to open the menu (new window).
Follow
PHE Home
Preparedness
Currently selected
Planning
Aligning Health Care Industry Cybersecurity Approaches
ASPR Playbooks
At-Risk, Behavioral Health...(ABC)
Coming in 2022: RISC Toolkit 2.0
Critical Infrastructure Protection
Cybersecurity TF
EPAP
Evaluation Branch
Gaps in Contraception Access and Zika
Health Care Readiness
HPP
Incident Response Framework
Last Mile
Legal Authority and Other Guidance
Medical Planning and Response Manual for a Nuclear Detonation Incident: A Practical Guide
Medical Surge Capacity Capability
National Emergency Tele Critical Care Network (NETCCN)
National Influenza Vaccine Modernization Strategy 2020-2030
National Plus
Notice of Funding Opportunity EP-HIT-21-004
International Preparedness and Response
Security and Prosperity Partnership
Southern Caucasus Collaboration and Partnership in Countering Biological Threats
Outbreak Response and Bioterrorism Investigation Trilateral Forum
Countering Biological Threats
North American Plan for Animal and Pandemic Influenza
U.S. Health Security National Action Plan: Strengthening Implementation of the International Health Regulations
Medical Countermeasures
HHS Retrospective on the 2009 H1N1 Influenza Pandemic
PHEMCE
BARDA Funds Medical Countermeasure Innovation
HHS Centers for Innovation in Advanced Development and Manufacturing
BARDA evaluates burn dressing for radiation, sulfur mustard burns
BARDA funds study of therapy for thermal burns
HHS explores new emergency response use for approved steroid
HHS funds development of freeze-dried platelets for disaster response
BARDA funds development of device to aid burn patients in disasters
New blood test would provide fast results for medical care after anthrax attack
BARDA boosts global ability to respond to pandemics
New diagnostic test to detect the presence of an influenza virus and identify its genetic profile
New device could reduce time needed to test for bacteria, such as anthrax
Mass decontamination research provides new scientific evidence for responders, hospitals to decontaminate chemical terrorism, accident survivors
HHS pursues fast, easy test for anthrax and multi-drug resistant anthrax infections
HHS pursues development of panels of blood-based biomarkers for several biothreat pathogens
BARDA funds advanced development of drug to treat injuries from exposure to cyanide
BARDA supports development of antitoxin administered as a traditional shot
BARDA funds development of drugs to treat injuries from chemical bioterrorism
Public Health and Medical Services Support
Emergency Preparedness
Emergency Support Function
Legal Authority of the Secretary
Medical Assistance
Medical Response
Medical Surge Capacity Capability
EMS and First Responders
Responders Clinicians & Practitioners
National Disaster Medical System
Regional Emergency Coordinators
Secretary's Operations Center
Guidance for Protecting Responders’ Health During the First Week Following A Wide-Area Aerosol Anthrax Attack
Frequently Asked Questions
Patient Decontamination Following Chemical Incidents
Ebola Preparedness for the U.S. Healthcare System
Response to Comments for Patient Decontamination in a Mass Chemical Exposure Incident: National Planning Guidance for Communities
National Survey of Health Insurance Plan Emergency Preparedness Report
Legal Authorities
Boards and Committees
Guidance
Pandemic and All Hazards Preparedness Act (PAHPA)
Public Health Resources
Public Readiness and Emergency Preparedness (PREP) Act
Public Health Emergency Declaration Q&As
Redirect to About 1135 Waivers
National Biodefense Strategy
2019 Biodefense Public Report
National Biodefense Strategy
Biodefense Summit
About the Biodefense Summit
Call for Public Comments: National Biodefense Strategy Implementation
Biodefense Summit Transcripts
Welcome Remarks
Opening Remarks
Importance of the Biodefense Summit
Evolution of U.S. Biodefense Policy
Recommendation and Perspective of the Blueprint for Biodefense
Goal 1: Enabling Risk Awareness to Inform Decision Making across the Biodefense Enterprise
Goal 1: Discussion Questions and Answers
Goal 2: Ensure Biodefense Enterprise Capabilities to Prevent Bioincidents
Goal 2: Discussion Questions and Answers
Goal 3: Ensure Biodefense Preparedness Enterprise to Reduce the Impacts of Bioincidents
Goal 3: Discussion Questions and Answers
About ASPR
BARDA
Redirect to Project Bioshield
ASPR 2020 Year in Review
ASPR Careers
Office of Acquisitions Management, Contracts & Grants
BARDA Broad Agency Announcement
Program Offices & Leadership
ASPR Program Offices
ASPR Program Offices and Leadership
Redirect to Dawn O'Connell on ASPR.HHS.gov
Redirect to Nikki Bratcher-Bowman on ASPR.HHS.gov
Redirect to Leadership Bio: Jonathan Greene on ASPR.HHS.gov
Redirect to Leadership Bio: Gary L. Disbrow on ASPR.HHS.gov
Strategic National Stockpile
Federal Medical Stations
SNS and the COVID-19 Response
CHEMPACK
sustaining
products
imats
Emergency-Preparedness-and-Response
Lisa-Dillard
Steve-Adams
about
responses
training
Global Responders
Redirect to aspr.hhs SNS Course Listings
ESAR-VHP
SuccessStories
DesertMarathon
H1N1-RI
HurricaneIrene
KansasTornado
National Advisory Committee on Children and Disasters Redirect
ASPR Next
ASPR Next Areas of Interest
ASPR Next Areas of Interest Graphic: Long Description
ASPR Next Innovation Day
ASPR Next Broad Agency Announcement (BAA) White Paper Template Instructions
Cloth Face Coverings
Do Your Part to Slow the Spread
Getting Your Cloth Face Mask
Frequently Asked Questions
Cloth Face Cover Label Information
Wear and Care
Cloth Face Masks at Residential and Healthcare Facilities
Cloth Face Masks in Schools
State Allocations
COVID-19 Monoclonal Antibody Therapeutics QR Code
COVID-19 Vaccine Workforce
Home
COVID-19: 2019 Novel Coronavirus Disease
Critical Infrastructure Protection for the Healthcare and Public Health Sectors Redirect
Redirect to the HPH RISC Toolkit
Đồ Che Mặt Bằng Vải
Emergency
News & Multimedia
Past Events Archive
Public Health Actions
Situation Reports
Prepare Respond Recover
Public Health Communications
Public Health Response
Sustained Recovery
Bioterrorism
Chemical Emergencies
HHS Capabilities
Mass Casualty
Natural Disasters
Stay Safe Before, During and After a Flood
Stay Safe Before, During and After a Tornado
Hurricane Preparedness
Winter Weather
Earthquake Preparedness
Tsunami Preparedness Week
Radiation Emergencies
Responder Tools and Resources
Stay Connected
Alabama Emergency Communications Resources
Alaska Emergency Communications Resources
Arizona Emergency Communications Resources
Arkansas Emergency Communications Resources
California Emergency Communications Resources
Colorado Emergency Communications Resources
Connecticut Emergency Communications Resources
Delaware Emergency Communications Resources
Florida Emergency Communications Resources
Georgia Emergency Communications Resources
Hawaii Emergency Communications Resources
Idaho Emergency Communications Resources
Illinois Emergency Communications Resources
Indiana Emergency Communications Resources
Iowa Emergency Communications Resources
Kansas Emergency Communications Resources
Kentucky Emergency Communications Resources
Louisiana Emergency Communications Resources
Maine Emergency Communications Resources
Maryland Emergency Communications Resources
Terrorist Threats
The mAbs Calculator
The mAbs Calculator
EPAP Redirect
Mascarillas de tela
Contribuya a detener la propagación del virus
Obtenga su mascarilla de tela
Uso y cuido
Preguntas frecuentes
Mascarillas de tela para centros residenciales y de atención médica
Mascarillas de tela en las escuelas
Medical Reserve Corps
2020 National MRC Network Summary
About the MRC
Contact Us
Become a Volunteer
Starting an MRC Unit
Unit Leader Resources
MRC Listservs
MRC Recruitment and Recognition Toolkit
MRC Registration Criteria
MRC Registration Criteria FAQs
MRC Two-Way Listserv Rules and Sign-Up
Updates & Reports
Monthly Report January 2021
MRC Redirect Page
MRC Updates and Reports
Monthly Report February 2021
Monthly Report March 2021
Monthly Report April 2021
Monthly Report May 2021
MRC Redirect Page
The Medical Reserve Corps
National Advisory Committee on Individuals with Disabilities and Disasters
National Advisory Committee on Seniors and Disasters
National Biodefense Strategy Redirect
Home
NDMS Help Desk
Home
Patient Decontamination
Public Health Response and Recovery
Recovery Redirect
Redirect for COVID-19 Resources for Pediatric Healthcare Leaders and Clinicians
Redirect to Biosafety Stewardship
Redirect to Aligning Health Care Industry Security Approaches
Site Contents
It looks like your browser does not have JavaScript enabled. Please turn on JavaScript and try again.
HHS Retrospective on the 2009 H1N1 Influenza Pandemic
PHEMCE
PHEMCE Multiyear Budget
PHEMCE Strategy
Redirect to PHEMCE SIP 2022 on ASPR.HHS.gov
BARDA Funds Medical Countermeasure Innovation
HHS Centers for Innovation in Advanced Development and Manufacturing
BARDA evaluates burn dressing for radiation, sulfur mustard burns
BARDA funds study of therapy for thermal burns
HHS explores new emergency response use for approved steroid
HHS funds development of freeze-dried platelets for disaster response
BARDA funds development of device to aid burn patients in disasters
New blood test would provide fast results for medical care after anthrax attack
BARDA boosts global ability to respond to pandemics
New diagnostic test to detect the presence of an influenza virus and identify its genetic profile
New device could reduce time needed to test for bacteria, such as anthrax
Mass decontamination research provides new scientific evidence for responders, hospitals to decontaminate chemical terrorism, accident survivors
HHS pursues fast, easy test for anthrax and multi-drug resistant anthrax infections
HHS pursues development of panels of blood-based biomarkers for several biothreat pathogens
BARDA funds advanced development of drug to treat injuries from exposure to cyanide
BARDA supports development of antitoxin administered as a traditional shot
BARDA funds development of drugs to treat injuries from chemical bioterrorism
Site Contents
Lists, Libraries, and other Apps
Documents
3 items
Modified 5 months ago
Images
26 items
Modified 5 months ago
Pages
40 items
Modified 5 months ago
Workflow Tasks
0 items
Modified 5 years ago
Subsites
HHS Retrospective on the 2009 H1N1 Influenza Pandemic
Modified 5 months ago
PHEMCE
Modified 5 months ago
